SGRZ — Stonepath Income Statement
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$7.63m
- $410.26m
Annual income statement for Stonepath, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2001 December 31st | R2002 December 31st | C2003 December 31st | C2004 December 31st | 2005 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15.6 | 123 | 220 | 367 | 410 |
Cost of Revenue | |||||
Gross Profit | 5.59 | 36.7 | 62 | 84.7 | 86.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 20.4 | 122 | 218 | 373 | 414 |
Operating Profit | -4.82 | 0.747 | 1.68 | -5.58 | -3.89 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.52 | 0.875 | 0.401 | -9.23 | -6.43 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.6 | 0.454 | -0.335 | -11.6 | -8.35 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -17.5 | 0.454 | -0.785 | -13 | -9.74 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -21.6 | 0.454 | -0.785 | -13 | -9.77 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.378 | 0.016 | 0.008 | -0.261 | -0.175 |
Dividends per Share |